Similarly, in a mouse model of Dravet syndrome due to Scn1a mutation, decreased Cacna1g expression results in a partial amelioration of disease phenotypes with improved survival and reduced spontaneous seizure frequency [37]. Here, CACNA1G is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.